MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential

Go back to MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
(NASDAQ: MTVA) Delayed: 1.70 -0.05 (2.86%)
Previous Close $1.75    52 Week High
Open $1.76    52 Week Low
Day High $1.81    P/E N/A 
Day Low $1.70    EPS
Volume 43,527